Endocrine Dysfunction and Immune Checkpoint Inhibitor Regimens

This systematic review and meta-analysis compares the incidence and risk of endocrine adverse events following treatment with US Food and Drug Administration-approved immune checkpoint inhibitor regimens.

http://ift.tt/2zAZBej